Rifacept is a prescription medicine that is available as a Tablet, Capsule. It is primarily used for the treatment of Tuberculosis. The alternative uses of Rifacept have also been explained below.
The right dosage of Rifacept depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Rifacept can also lead to other problems, which have been listed below. These side effects of Rifacept are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Rifacept has a Mild effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Rifacept has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rifacept related warnings section.
Rifacept is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease are examples of such conditions. The section on Rifacept contraindications lists all such conditions.
Drug interactions for Rifacept have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Rifacept is safe while driving, and is addiction.
Rifacept is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Based on research, the following side effects have been observed when Rifacept is used -
Is the use of Rifacept safe for pregnant women?
Pregnant women may get mild side effects from Rifacept.
Is the use of Rifacept safe during breastfeeding?
Rifacept may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Rifacept, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Rifacept.
What is the effect of Rifacept on the Kidneys?
There are no side effects of Rifacept on the kidneys.
What is the effect of Rifacept on the Liver?
There may be an adverse effect on the liver after taking Rifacept. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Rifacept on the Heart?
There are no any side effects of Rifacept for the heart.
Rifacept should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Mild
If you are suffering from any of the following diseases, you should not take Rifacept unless your doctor advises you to do so -
Is this Rifacept habit forming or addictive?
Rifacept does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Rifacept since it will not make you feel sleepy.
Is it safe?
Yes, Rifacept is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Rifacept cannot treat any kind of mental disorder.
Interaction between Food and Rifacept
Taking Rifacept with food is safe.
Interaction between Alcohol and Rifacept
Consumption of alcohol and Rifacept together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768